🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Anna K. Nowak

Inserm

ORCID: 0000-0002-9317-9526

Also affiliated with Université de Lille, Centre Hospitalier Universitaire de Lille, Centre de Recherche en Cancérologie de Lyon, Onco Lille, CANTHER - Hétérogénéité, Plasticité et Résistance aux Thérapies des Cancers

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile
1.0Author DataRank

Indexed papers

3in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

The International Association for the Study of Lung Cancer Pleural Mesothelioma Staging Project: Expanded Database to Inform Revisions in the Ninth Edition of the TNM Classification of Pleural Mesothelioma

Journal of Thoracic Oncology(2024)10.1016/j.jtho.2024.01.018
Top 35%
0.557DataRank
Top 35%24 citations

Megan Eisele, Dorothy J. Giroux, Ritu R. Gill, Anna K. Nowak, Andrea Billè +9 more

Papers

Driven by 10 papers — median percentile 62. Top paper: “First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743”.

First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743

Annals of Oncology(2022)10.1016/j.annonc.2022.01.074
N/A
5.7DataRank · unranked
265 citations

Arnaud Scherpereel, Robin Cornelissen, Youssef Oulkhouir, Laurent Greillier, Kaplan Ma +15 more

Anetumab ravtansine versus vinorelbine in patients with relapsed, mesothelin-positive malignant pleural mesothelioma (ARCS-M): a randomised, open-label phase 2 trial

The Lancet Oncology(2022)10.1016/s1470-2045(22)00061-4
N/A
1.5DataRank · unranked
69 citations

Silvia Novello, Alessandra Bearz, Giovanni Luca Ceresoli, Joachim G.J.V. Aerts, James Spicer +22 more

The International Association for the Study of Lung Cancer Pleural Mesothelioma Staging Project: Expanded Database to Inform Revisions in the Ninth Edition of the TNM Classification of Pleural Mesothelioma

Journal of Thoracic Oncology(2024)10.1016/j.jtho.2024.01.018
Top 35%
0.557DataRank
Top 35%24 citations

Megan Eisele, Dorothy J. Giroux, Ritu R. Gill, Anna K. Nowak, Andrea Billè +9 more

The International Association for the Study of Lung Cancer Pleural Mesothelioma Staging Project: Updated Modeling of Prognostic Factors in Pleural Mesothelioma

Journal of Thoracic Oncology(2023)10.1016/j.jtho.2023.08.005
Top 40%
0.472DataRank
Top 40%12 citations

Adam Rosenthal, Dorothy J. Giroux, Anna K. Nowak, Andrea Billè, Marc de Perrot +6 more

Does CA125 binding to mesothelin impact the detection of malignant mesothelioma?

Lung Cancer(2013)10.1016/j.lungcan.2012.12.008
N/A
0.269DataRank · unranked
5 citations

Ian M. Dick, Hanne Dare, Yvonne Demelker, Anna K. Nowak, Arthur William Musk +2 more

The International Association for the Study of Lung Cancer Pleural Mesothelioma Staging Project: Proposal for Revision of the TNM Stage Groupings in the Forthcoming (Ninth) Edition of the TNM Classification for Pleural Mesothelioma

Journal of Thoracic Oncology(2024)10.1016/j.jtho.2024.05.002
N/A
0DataRank · unranked
28 citations

Dorothy J. Giroux, Megan Eisele, Adam Rosenthal, Andrea Billè, Ritu R. Gill +9 more

The International Association for the Study of Lung Cancer Mesothelioma Staging Project: Proposals for Revisions of the “T” Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Pleural Mesothelioma

Journal of Thoracic Oncology(2024)10.1016/j.jtho.2024.03.007
N/A
0DataRank · unranked
38 citations

Anna K. Nowak, Dorothy J. Giroux, Megan Eisele, Adam Rosenthal, Hedy L. Kindler +10 more

Reprogramming the anti-tumor immune response via CRISPR genetic and epigenetic editing

Molecular Therapy — Methods & Clinical Development(2021)10.1016/j.omtm.2021.04.009
N/A
0DataRank · unranked
35 citations

Shahama Taifour, Riccardo Dolcetti, Jonathan Chee, Anna K. Nowak, Silvana Gaudieri +2 more

The International Association for the Study of Lung Cancer Mesothelioma Staging Project: Proposals for the “N” Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Pleural Mesothelioma

Journal of Thoracic Oncology(2024)10.1016/j.jtho.2024.05.003
N/A
0DataRank · unranked
19 citations

R. Taylor Ripley, Dorothy J. Giroux, Ritu R. Gill, Hedy L. Kindler, Anna K. Nowak +6 more

The International Association for the Study of Lung Cancer Mesothelioma Staging Project: Proposals for the M Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Pleural Mesothelioma

Journal of Thoracic Oncology(2024)10.1016/j.jtho.2024.08.022
N/A
0DataRank · unranked
18 citations

Adam Rosenthal, Dorothy J. Giroux, Anna K. Nowak, Andrea Billè, Ritu R. Gill +8 more